Current Hepatitis Reports

, 8:103

HIV and coinfected patients

Authors

    • Department of Medicine/Liver DiseasesMount Sinai School of Medicine
  • Douglas T. Dieterich
Article

DOI: 10.1007/s11901-009-0015-9

Cite this article as:
Vachon, M. & Dieterich, D.T. Curr hepatitis rep (2009) 8: 103. doi:10.1007/s11901-009-0015-9
  • 48 Views

Abstract

HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV) infections are major public health problems. Patients at risk for HIV infection are likely also at risk for HCV and HBV because of shared routes of transmission. HIV and antiretroviral therapy (ART) have a significant impact on HCV and HBV. HIV coinfection accelerates HCV and HBV natural history, leading to an increased incidence of cirrhosis, development of hepatocellular carcinoma (HCC), and death. Universal screening for HCV and HBV infections in HIV-infected patients is essential. Proper screening combined with up-to-date treatment strategies can prevent these complications. This review focuses on important aspects and recent developments in the rapidly evolving field of coinfection.

Download to read the full article text

Copyright information

© Current Medicine Group, LLC 2009